Bruce Culleton - Aug 1, 2023 Form 4 Insider Report for PROKIDNEY CORP. (PROK)

Role
EVP, Clinical Development
Signature
/s/ Todd Girolamo, attorney in fact
Stock symbol
PROK
Transactions as of
Aug 1, 2023
Transactions value $
$0
Form type
4
Date filed
8/3/2023, 08:52 AM
Previous filing
Jul 25, 2023
Next filing
Dec 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PROK Employee stock option (right to buy) Award $0 +485K $0.00 485K Aug 1, 2023 Class A Ordinary Shares 485K $13.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on 1st anniversary of August 1, 2023 and the remaining 75% vests in substantially equal monthly installments for 36 months thereafter.